Last 12 months
Inside the activity.
0 purchase rows · 143 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 34 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 92 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2012 Filed Nov 15, 2012 21:39 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 21,600 | $61.34 | $1,324,944.00 |
DisclosureSEC source: 0001127602-12-030976 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,736 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.51, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:39 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 21,600 | $36.10 | $779,760.00 |
DisclosureSEC source: 0001127602-12-030976 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:41 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,500 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001127602-12-030977 · form4.xml · derivative · entry 5 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,500 shares Expires 2013-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option originally was to have vested in three equal annual installments beginning on May 24, 2007, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:41 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,600 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-030977 · form4.xml · derivative · entry 4 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,600 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal installments on November 9, 2007, 2008 and 2009. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:41 UTC |
ULLIAN ELAINEDirector
|
SaleCommon Stock | 26,100 | $61.51 | $1,605,411.00 |
DisclosureSEC source: 0001127602-12-030977 · form4.xml · nonDerivative · entry 3 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,109 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.46 to $61.57, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:41 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionCommon Stock | 10,500 | $36.75 | $385,875.00 |
DisclosureSEC source: 0001127602-12-030977 · form4.xml · nonDerivative · entry 2 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:41 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionCommon Stock | 15,600 | $43.37 | $676,572.00 |
DisclosureSEC source: 0001127602-12-030977 · form4.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2012 Filed Nov 15, 2012 21:43 UTC |
Jacks TylerDirector
|
SaleCommon Stock | 2,509 | $61.32 | $153,851.88 |
DisclosureSEC source: 0001127602-12-030979 · form4.xml · nonDerivative · entry 1 Jacks Tyler · CIK 0001464237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.30 to $61.35, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Cancel Read SEC document |
| November 01, 2012 Filed Nov 2, 2012 20:50 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-029633 · form4.xml · derivative · entry 3 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,900 Underlying: Common Stock · 125,000 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal annual installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| November 01, 2012 Filed Nov 2, 2012 20:50 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 125,000 | $62.49 | $7,811,250.00 |
DisclosureSEC source: 0001127602-12-029633 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,334.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2012. Read SEC document |
| November 01, 2012 Filed Nov 2, 2012 20:50 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 125,000 | $43.37 | $5,421,250.00 |
DisclosureSEC source: 0001127602-12-029633 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,334.53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2012 Filed Nov 5, 2012 22:22 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-029796 · form4.xml · derivative · entry 4 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 30,000 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| November 01, 2012 Filed Nov 5, 2012 22:22 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 30,000 | $62.00 | $1,860,000.00 |
DisclosureSEC source: 0001127602-12-029796 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,643 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2012. Read SEC document |
| November 01, 2012 Filed Nov 5, 2012 22:22 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionCommon Stock | 30,000 | $43.37 | $1,301,100.00 |
DisclosureSEC source: 0001127602-12-029796 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2012 Filed Oct 2, 2012 16:32 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 382.46 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-12-042279 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,705.76 Underlying: Common Stock · 382.46 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of September 29, 2012, at a price of $58.83 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of September 29, 2012, at a price of $58.83 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of September 29, 2012, at a price of $58.83 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 19:02 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,740 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-026449 · form4.xml · derivative · entry 5 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,740 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 19:02 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
SaleCommon Stock | 5,740 | $60.79 | $348,934.60 |
DisclosureSEC source: 0001127602-12-026449 · form4.xml · nonDerivative · entry 3 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,551 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2012. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 19:02 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 5,740 | $43.37 | $248,943.80 |
DisclosureSEC source: 0001127602-12-026449 · form4.xml · nonDerivative · entry 2 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 19:02 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
SaleCommon Stock | 1,553 | $60.00 | $93,180.00 |
DisclosureSEC source: 0001127602-12-026449 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,551 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2012. Read SEC document |
| September 10, 2012 Filed Sep 11, 2012 21:15 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-026117 · form4.xml · derivative · entry 3 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 30,000 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| September 10, 2012 Filed Sep 11, 2012 21:15 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 30,000 | $59.00 | $1,770,000.00 |
DisclosureSEC source: 0001127602-12-026117 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,899 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2012. Read SEC document |
| September 10, 2012 Filed Sep 11, 2012 21:15 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionCommon Stock | 30,000 | $43.37 | $1,301,100.00 |
DisclosureSEC source: 0001127602-12-026117 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2012 Filed Sep 11, 2012 21:12 UTC |
SORENSEN LARS REBIENDirector
|
Tax withholdingCommon Stock | 712 | $58.93 | $41,958.16 |
DisclosureSEC source: 0001127602-12-026115 · form4.xml · nonDerivative · entry 1 SORENSEN LARS REBIEN · CIK 0001225514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,113 Read SEC document |
| September 06, 2012 Filed Sep 7, 2012 20:46 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,360 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-025971 · form4.xml · derivative · entry 4 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,360 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| September 06, 2012 Filed Sep 7, 2012 20:46 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 11,360 | $58.00 | $658,880.00 |
DisclosureSEC source: 0001127602-12-025971 · form4.xml · nonDerivative · entry 2 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 30, 2012. Read SEC document |
| September 06, 2012 Filed Sep 7, 2012 20:46 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 11,360 | $43.37 | $492,683.20 |
DisclosureSEC source: 0001127602-12-025971 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2012 Filed Sep 4, 2012 20:36 UTC |
WILVER PETER MSr. VP & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $34.86 | $0.00 |
DisclosureSEC source: 0001127602-12-025636 · form4.xml · derivative · entry 5 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2013-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option originally was to have vested in three equal annual installments beginning on February 27, 2007, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc. Read SEC document |
| August 31, 2012 Filed Sep 4, 2012 20:36 UTC |
WILVER PETER MSr. VP & CFO
|
SaleCommon Stock | 65,000 | $57.25 | $3,721,250.00 |
DisclosureSEC source: 0001127602-12-025636 · form4.xml · nonDerivative · entry 2 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,224 Read SEC document |
| August 31, 2012 Filed Sep 4, 2012 20:36 UTC |
WILVER PETER MSr. VP & CFO
|
Exercise / conversionCommon Stock | 65,000 | $34.86 | $2,265,900.00 |
DisclosureSEC source: 0001127602-12-025636 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2012 Filed Aug 8, 2012 21:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 80,800 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-024121 · form4.xml · derivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,800 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010 and 2011. Read SEC document |
| August 07, 2012 Filed Aug 8, 2012 21:41 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 80,800 | $57.27 | $4,627,416.00 |
DisclosureSEC source: 0001127602-12-024121 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,517 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.23 to $57.48, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2012 Filed Aug 8, 2012 21:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 80,800 | $43.37 | $3,504,296.00 |
DisclosureSEC source: 0001127602-12-024121 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2012 Filed Aug 7, 2012 21:25 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 38,340 | $0.00 Strike: $31.31 | $0.00 |
DisclosureSEC source: 0001127602-12-023982 · form4.xml · derivative · entry 3 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,340 shares Expires 2015-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 15,336 options vested on 12/31/05; 15,336 options vested on 12/31/06; and 7,668 options vested on 12/31/07. Read SEC document |
| August 03, 2012 Filed Aug 7, 2012 21:25 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 38,340 | $56.30 | $2,158,542.00 |
DisclosureSEC source: 0001127602-12-023982 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,899 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.19 to $56.45, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2012 Filed Aug 7, 2012 21:25 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionCommon Stock | 38,340 | $31.31 | $1,200,425.40 |
DisclosureSEC source: 0001127602-12-023982 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2012 Filed Aug 2, 2012 21:30 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 17,836 | $56.01 | $998,994.36 |
DisclosureSEC source: 0001127602-12-023641 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,517 Read SEC document |
| July 31, 2012 Filed Aug 2, 2012 21:30 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 6,940 | $55.90 | $387,946.00 |
DisclosureSEC source: 0001127602-12-023641 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,353 Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 21:26 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-023254 · form4.xml · derivative · entry 4 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,360 Underlying: Common Stock · 12,000 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 21:26 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 17,667 | $56.17 | $992,355.39 |
DisclosureSEC source: 0001127602-12-023254 · form4.xml · nonDerivative · entry 2 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,166 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.13 to $56.26, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 30, 2012 Filed Jul 31, 2012 21:26 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 12,000 | $43.37 | $520,440.00 |
DisclosureSEC source: 0001127602-12-023254 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 30, 2012 21:26 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 15,000 | $55.82 | $837,300.00 |
DisclosureSEC source: 0001127602-12-023160 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,899 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.77 to $55.91, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 30, 2012 Filed Jul 3, 2012 15:24 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 433.44 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-011054 · edgar.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,323.3 Underlying: Common Stock · 433.44 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1 for 1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of June 30, 2012, at a price of $51.91 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of June 30, 2012, at a price of $51.91 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of June 30, 2012, at a price of $51.91 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:29 UTC |
Parrett William GDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018306 · form4.xml · nonDerivative · entry 1 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,449 Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:30 UTC |
MANZI JIM PDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018309 · form4.xml · nonDerivative · entry 1 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,908 Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:32 UTC |
LYNCH THOMAS JDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018311 · form4.xml · nonDerivative · entry 1 LYNCH THOMAS J · CIK 0001208323 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,909 Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:32 UTC |
LEWENT JUDY CDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018312 · form4.xml · nonDerivative · entry 1 LEWENT JUDY C · CIK 0001140890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,449 Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:34 UTC |
Jacks TylerDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018315 · form4.xml · nonDerivative · entry 1 Jacks Tyler · CIK 0001464237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,009 Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:35 UTC |
ULLIAN ELAINEDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018316 · form4.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,109 Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:37 UTC |
SORENSEN LARS REBIENDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018319 · form4.xml · nonDerivative · entry 1 SORENSEN LARS REBIEN · CIK 0001225514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,825 Read SEC document |
| May 23, 2012 Filed May 25, 2012 21:38 UTC |
HARRIS C MARTINDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018320 · form4.xml · nonDerivative · entry 1 HARRIS C MARTIN · CIK 0001236982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,452 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.